PVI
CGEM icon

Pura Vida Investments’s Cullinan Oncology CGEM Stock Holding History

Pura Vida Investments’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-81,418
Closed -$1.84M – 248
2021
Q3 		$1.84M Sell
81,418
-159,380
-66% -$4.26M 0.06% 195
2021
Q2 		$6.2M Buy
240,798
+24,168
+11% +$743K 0.19% 102
2021
Q1 		$9.03M Buy
+216,630
New +$8.79M 0.26% 78

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Pura Vida Investments's CGEM Position: Q4 2021 in Review

Pura Vida Investments sold out of Cullinan Oncology (CGEM) in Q4 2021, closing a stake of 81,418 shares — an estimated $1.84M sold.

Pura Vida Investments first reported a position in CGEM in Q1 2021 and held it in 3 quarters. The position peaked at $9.03M in Q1 2021. 75 funds tracked by Wall St. Rank hold CGEM as of Q4 2021.

  • Pura Vida Investments reported no remaining Cullinan Oncology position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 81,418 Cullinan Oncology shares in Q4 2021, an estimated $1.84M.
  • Pura Vida Investments first reported a position in Cullinan Oncology in Q1 2021 and held it in 3 quarters.
  • Pura Vida Investments's Cullinan Oncology position peaked at $9.03M in Q1 2021.
  • 75 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.